Literature DB >> 9202382

Genetic evidence for 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) as a negative effector of cytochrome terminal oxidase cbb3 production in Rhizobium etli.

M Soberón1, O Lopez, J Miranda, M L Tabche, C Morera.   

Abstract

A Rhizobium etli Tn5mob-induced mutant (CFN035) exhibits an enhanced capacity to oxidize N,N,N',N', tetramethyl-p -phenylenediamine (TMPD), a presumptive indicator of elevated cytochrome c terminal oxidase activity. Sequencing of the mutated gene in CFN035 revealed that it codes for the amidophosphoribosyl transferase enzyme (PurF) that catalyzes the first step in the purine biosynthetic pathway. Two c-type cytochromes with molecular weights of 32 and 27 kDa were produced in strain CFN035, which also produced a novel CO-reactive cytochrome (absorbance trough at 553 nm), in contrast to strain CE3 which produced a single 32 kDa c-type protein and did not produce the 553 nm CO-reactive cytochrome. A wild-type R. etli strain that expresses the Bradyrhizobium japonicum fixNOQP genes, which code for the symbiotic cytochrome terminal oxidase cbb3, produced similar absorbance spectra (a trough at 553 nm in CO-difference spectra) and two c-type proteins similar in size to those of strain CFN035, suggesting that CFN035 also produces the cbb3 terminal oxidase. The expression of a R. etli fixN-lacZ gene fusion was measured in several R. etli mutants affected in different steps of the purine biosynthetic pathway. Our analysis showed that purF, purD, purQ, purL, purY, purK and purE mutants expressed three-fold higher levels of the fixNOQP operon than the wild-type strain. The derepressed expression of fixN was not observed in a purH mutant. The purH gene product catalyzes the conversion of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to 5-form-aminoimidazole-4-carboxamide ribonucleotide (FAICAR) and inosine. Supplementation with AICA riboside lowered the levels of fixN expression in the purF mutants. These data are consistent with the possibility that AICAR, or a closely related metabolite, is a negative effector of the production of the symbiotic terminal oxidase cbb3 in R. etli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202382     DOI: 10.1007/s004380050464

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  7 in total

1.  Enhanced nitrogen fixation in a rhizobium etli ntrC mutant that overproduces the bradyrhizobium japonicum symbiotic terminal oxidase cbb3

Authors: 
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

2.  The Mesorhizobium loti purB gene is involved in infection thread formation and nodule development in Lotus japonicus.

Authors:  Shin Okazaki; Yoshiyuki Hattori; Kazuhiko Saeki
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

3.  Regulation of gene expression in response to oxygen in Rhizobium etli: role of FnrN in fixNOQP expression and in symbiotic nitrogen fixation.

Authors:  O Lopez; C Morera; J Miranda-Rios; L Girard; D Romero; M Soberón
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

4.  Enhanced symbiotic performance by Rhizobium tropici glycogen synthase mutants.

Authors:  S Marroquí; A Zorreguieta; C Santamaría; F Temprano; M Soberón; M Megías; J A Downie
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

5.  Expression of thiamin biosynthetic genes (thiCOGE) and production of symbiotic terminal oxidase cbb3 in Rhizobium etli.

Authors:  J Miranda-Ríos; C Morera; H Taboada; A Dávalos; S Encarnación; J Mora; M Soberón
Journal:  J Bacteriol       Date:  1997-11       Impact factor: 3.490

6.  Plasticity in the purine-thiamine metabolic network of Salmonella.

Authors:  Jannell V Bazurto; Diana M Downs
Journal:  Genetics       Date:  2010-12-06       Impact factor: 4.562

7.  Metabolic flux in both the purine mononucleotide and histidine biosynthetic pathways can influence synthesis of the hydroxymethyl pyrimidine moiety of thiamine in Salmonella enterica.

Authors:  Shara Allen; Julie L Zilles; Diana M Downs
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.